×
App Icon
The Standard e-Paper
Kenya's Bold Newspaper
★★★★ - on Play Store
Download Now

US vaccine giant Moderna 'suspends' plans to build Sh65b plant in Kenya

Moderna Inc inked a deal in 2022 with the Kenyan government to invest billions of shillings in a facility that would produce up to 500 million vaccine shots a year. [iStsockphoto]

US biotechnology giant Moderna says it has suspended plans to build a vaccine Sh65 billlion plant in Kenya.

The American firm inked a deal in 2022 with the Kenyan government to invest billions of shillings in a facility that would produce up to 500 million vaccine shots a year.

Get Full Access for Ksh299/Week
Bold Reporting Takes Time, Courage and Investment. Stand With Us.
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in
Business
Ratings agency Fitch gives Kenya a stable outlook, easing debt fears
Business
Kenya Pipeline IPO shares to be allocated pro rata, advisor says
Business
Trade ministry seeks urgent action on VAT refunds
Business
KPA, KRA bosses meet Mombasa port players as congestion persists